The Gastrointestinal & Inflammation (GI2) Therapeutic Area Lead in DMPK&M provides scientific and strategic leadership across the pipeline, talent, and strategy. The role supervises DMPK&M project representatives and Modeling & Simulation (M&S) scientists who support Takeda’s GI2 research pipeline. It oversees DMPK&M strategy for the GI2 portfolio, execution of project plans, translation and dose optimization strategies, and review of regulatory filings. The role contributes to therapeutic-area discussions and partners with cross-functional stakeholders to align with Takeda’s strategic framework. As a member of the Global DMPK&M leadership team, it contributes to portfolio strategy and global business operations, helps shape department strategy and culture, and strengthens partnerships across Research and Development. The position provides scientific guidance on stage-appropriate DMPK&M questions to support selection and development of clinical candidates with optimal drug-development characteristics. It builds external scientific networks, advises on and approves milestone presentations and PRC narratives, and oversees regulatory activities, including review and approval of fit-for-purpose submission packages for GI2. It represents DMPK&M in governance discussions, aligns functional strategy with DDU and TAU portfolio goals, collaborates with senior leaders on needs and execution plans, supports project resourcing, and reviews in-licensing evaluations for the therapeutic area.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Senior
Education Level
Ph.D. or professional degree